Liquid biopsy Conferences and Events

Liquid biopsy refers to the analysis of disease-related information in body fluids, especially blood, rather than relying only on tissue biopsies. It can measure circulating tumor DNA, circulating tumor cells, extracellular vesicles, exosomes, RNA, proteins, metabolites, and other biomarkers. In biotechnology and nanomedicine, liquid biopsy depends on sensitive detection, sample processing, molecular profiling, and nanoscale or microfluidic platforms that can capture rare signals from complex biological fluids.

Liquid biopsy matters because it can provide minimally invasive information about cancer, treatment response, resistance, recurrence, and disease evolution. It is also relevant to prenatal testing, transplant monitoring, infectious disease, and chronic disease research. Key challenges include sensitivity, specificity, pre-analytical variability, standardization, interpretation, and clinical validation. The field connects closely to biomarkers, extracellular vesicles, diagnostics, and precision medicine.

Conferences on liquid biopsy appear in oncology, diagnostics, biotechnology, genomics, nanomedicine, and clinical research programs. Sessions often cover circulating tumor DNA, exosomes, single-cell analysis, assay validation, early detection, and minimal residual disease. Tracking liquid-biopsy events helps researchers follow a fast-moving diagnostic field that is changing how disease is monitored over time.